Threat actors are exploiting complex routing scenarios and misconfigured spoof protections to send spoofed phishing emails, ...

MIPS S8200 NPU is sampling now to lead customers developing autonomous edge transportation, robotics, and embedded platforms ...

Pursuant to the Agreement, Hunan Saitumofei has granted Shanghai Benke exclusive distribution rights for the Analyzer in East China, covering Jiangsu Province, Shanghai Municipality, and Zhejiang ...

RedChip Companies will air interviews with Processa Pharmaceuticals, Inc. (Nasdaq:PCSA) and 60 Degrees Pharmaceuticals, Inc. ...

According to DataM Intelligence, the global cell and gene therapy market reached a value of US$13.90 billion in 2024 and is ...

MicroCloud Hologram Inc. (NASDAQ: HOLO), ("HOLO" or the "Company"), a technology service provider, launched Q-DPC Accelerator, which is an innovative tool that relies on the quantum-enhanced density ...

In the second in our series on the latest EW BrightSparks of 2025, we profile Nikolas Bruce, a PhD Research Student at ...

Precision BioSciences offers high-risk, high-reward potential, trading below cash with key HBV and DMD data catalysts ...

Bridgewater: Amneal Pharma and mAbxience, a Fresenius Kabi majority-owned group with partial ownership from Insud Pharma, ...

Approvals expand Amneal’s biosimilars portfolioCompany expects to commercialize six biosimilars across eight presentations by 2027BRIDGEWATER, ...

Amid concerns over increasing symptoms of leptospirosis, Gaza's Health Ministry reportedly says there are no confirmed cases.

Amneal Pharma receives US FDA approval for denosumab biosimilars Prolia and Xgeva: Bridgewater, New Jersey Friday, December 26, 2025, 16:00 Hrs [IST] Bridgewater headquartered Amn ...